Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,084.00
+23.80 (1.16%)
Feb 9, 2026, 3:29 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 850.46 billion as of February 9, 2026. Its market cap has decreased by -19.59% in one year.
Market Cap
850.46B
Enterprise Value
901.59B
Revenue
139.14B
Ranking
n/a
PE Ratio
47.68
Stock Price
2,084.00
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 850.46B, an increase of 49.27%. That is a compound annual growth rate of 15.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 859.42B | -5.22% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.60T |
| Cipla | 1.07T |
| Zydus Lifesciences | 893.69B |
| Aurobindo Pharma | 691.73B |
| Alkem Laboratories | 679.61B |
| Glenmark Pharmaceuticals | 546.00B |
| Laurus Labs | 513.16B |
| Ipca Laboratories | 359.42B |